Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Clinical trial NCT06183489 · RECRUITING
Trial details
- NCT number
- NCT06183489
- Sponsor
- Stichting European Myeloma Network
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-14
- Primary completion
- 2027-07-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.